| Bioactivity | FX-06 (Fibrin-derived peptide Bβ15-42) is a fibrin Bbeta chain-derived peptide. FX-06 binds to VE-cadherin and inhibits leukocyte transmigration and initiates VE-cadherin-mediated signaling. FX-06 can be used in the research of ischemia/reperfusion injury, Dengue shock syndrome (DSS)[1][2][4]. |
| Invitro | FX-06 (50 μM, 3 days) inhibits the production of D2HG in HEK-293T cells transfected with IDH1 R132H[2]. |
| Name | FX-06 |
| CAS | 88650-17-3 |
| Shortening | GHRPLDKKREEAPSLRPAPPPISGGGYR |
| Formula | C133H216N44O38 |
| Molar Mass | 3039.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
FX-06
CAS: 88650-17-3 F: C133H216N44O38 W: 3039.41
FX-06 (Fibrin-derived peptide Bβ15-42) is a fibrin Bbeta chain-derived peptide. FX-06 binds to VE-cadherin and inhibits
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.